Sponsor · clinical trials

University Health Network, Toronto clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Canada, Australia, Spain, Italy, Singapore, Ireland, France, Belgium, Switzerland, Austria, Brazil and Israel registers with University Health Network, Toronto as lead sponsor. Synced 12 Nov 2026

356Current trials

204Recruiting now

128Drugs in these trials

12Trial registers

Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany

Compiled from ClinicalTrials.gov and CTIS registry records · Synced 12 Nov 2026 · Editorial standards

At a glance

University Health Network, Toronto is the lead sponsor of 356 current clinical trials in our Canada, Australia, Spain, Italy, Singapore, Ireland, France, Belgium, Switzerland, Austria, Brazil and Israel registers. 204 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Cisplatin, Cyclophosphamide and Carboplatin. The most-studied condition is Breast Cancer.

ClinicalTrials.gov trials by status

Recruiting20457%
Not yet open3510%
Active, closed11031%
By invitation72%

Trials by phase

Not applicable15243%
Observational8624%
Phase 26619%
Phase 1164%
Phase 3144%
Phase 493%
Early Phase 151%
Phase 2/351%
Phase 1/231%

Clinical trials sponsored by University Health Network, Toronto

356 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach NCT06050707 · ClinicalTrials.gov ↗ · Anal Squamous Cell Carcinoma	Phase 2	Recruiting	2023-09	Canada, Australia
Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK) NCT07524114 · ClinicalTrials.gov ↗ · Breast Cancer, Lung Cancer, Melanoma	Observational	Recruiting	2026-03	Canada
Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era NCT06508567 · ClinicalTrials.gov ↗ · Prostate Cancer Recurrent, Prostate Cancer	Not applicable	Recruiting	2024-08	Canada
LIFUS For Neurological Disorders NCT07417280 · ClinicalTrials.gov ↗ · Parkinson's Disease (PD), Essential Tremor, Orthostatic Tremor	Not applicable	Recruiting	2025-12	Canada
Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma NCT07112170 · ClinicalTrials.gov ↗ · Metastatic Melanoma, OligoProgressive Metastatic Disease	Not applicable	Recruiting	2025-07	Canada
Brain Imaging Biomarkers in Patients With Brain Metastasis NCT04197297 · ClinicalTrials.gov ↗ · Brain Metastases, Adult	Phase 2	Recruiting	2021-10	Canada
A Study to Evaluate Zanubrutinib and Tislelizumab in Progressive Lymphoma Post CAR-T NCT06167785 · Large B-cell Lymphoma Drugs: Tislelizumab, Zanubrutinib	Phase 2	Recruiting	2025-06	Canada
Cerebellar Deep Brain Stimulation for the Treatment of Ataxia NCT07427563 · ClinicalTrials.gov ↗ · Ataxia, Gait	Not applicable	Recruiting	2023-03	Canada
Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL NCT05963217 · ClinicalTrials.gov ↗ · Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic Lymphoma Drugs: Cyclophosphamide, Fludarabine	Phase 1	Recruiting	2023-07	Canada
ODYSSEE Kidney Health Trial NCT06274710 · ClinicalTrials.gov ↗ · Chronic Kidney Diseases	Not applicable	Recruiting	2023-12	Canada
Platform of Randomized Adaptive Clinical Trials in Critical Illness NCT05440851 · ClinicalTrials.gov ↗ · Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High	Not applicable	Recruiting	2023-04	Spain, Italy, Canada, Singapore, Australia
Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness NCT07339943 · ClinicalTrials.gov ↗ · Prostate Cancer (Adenocarcinoma), Low and Intermediate Risk Prostate Cancer	Not applicable	Recruiting	2025-04	Canada
FAZA PETMRI Gastro-Oesophageal Study NCT04560036 · ClinicalTrials.gov ↗ · Metastasized Gastro-Oesophageal Cancer	Not applicable	Recruiting	2020-09	Canada
Using Tumor Models to Determine Treatments NCT06813079 · ClinicalTrials.gov ↗ · Pancreatic Ductal Carcinoma, Advanced Cancer, Epithelial Tumor Drugs: Abemaciclib, Brigatinib, Ceritinib	Phase 2	Recruiting	2025-04	Canada
Feasibility Trial of Glofitamab in a Response Adapted Approach Incorporating Interim FDG PET and ctDNA to Optimize Primary Therapy of DLBCL (GRAIL) NCT06050694 · ClinicalTrials.gov ↗ · Diffuse Large B Cell Lymphoma (DLBCL) Drug: Glofitamab	Phase 2	Recruiting	2025-01	Canada
Clinical Outcomes of Pregnant Individuals With Epilepsy - Prospective Study NCT05485649 · ClinicalTrials.gov ↗ · Epilepsy	Observational	Recruiting	2022-07	Canada
Dose Efficacy in Adhesive Capsulitis NCT06848374 · ClinicalTrials.gov ↗ · Adhesive Capsulitis of the Shoulder Drug: Methylprednisolone	Phase 3	Recruiting	2024-12	Canada
EXtubation Related Complications - the EXTUBE Study (EXTUBE) NCT06442930 · Extubation	Observational	Recruiting	2025-04	Ireland, Canada, Singapore, Australia
End-on Versus Parallel Radiofrequency Lesioning for Neurotomy of the Cervical Medial Branch Nerves NCT05818774 · ClinicalTrials.gov ↗ · Neck Pain, Zygapophyseal Joint Arthritis	Not applicable	Recruiting	2023-03	Spain, Canada
Digital Peer Navigation for Adolescents and Young Adults With Cancer NCT06193369 · ClinicalTrials.gov ↗ · Lymphoma, Breast Cancer, Testicular Cancer	Not applicable	Recruiting	2024-08	Canada
Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis NCT06220526 · ClinicalTrials.gov ↗ · Suspected Sarcoidosis	Not applicable	Recruiting	2023-08	Canada
Intravenous vs Oral Acetaminophen in Postoperative Hip Fracture Adult Patients NCT05425355 · ClinicalTrials.gov ↗ · Hip-fracture, Surgery	Phase 4	Recruiting	2023-01	Canada
A Comprehensive Multiomic Biomarker Evaluation Across Two Single-arm Cohorts to Elucidate Mechanisms of Response and Resistance in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) NCT07408063 · ClinicalTrials.gov ↗ · Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Drugs: Dostarlimab, Ris-Rez	Phase 2	Recruiting	2026-04	Canada
IVIM & OLINK in Sarcoma NCT05950594 · ClinicalTrials.gov ↗ · Soft Tissue Sarcoma	Phase 2	Recruiting	2024-03	Canada
The HIMALAYAS Trial and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled Trial NCT05023785 · ClinicalTrials.gov ↗ · Heart Failure, Cardiotoxicity, Cancer	Not applicable	Recruiting	2024-01	Canada
PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction Evaluation NCT04901884 · ClinicalTrials.gov ↗ · Pulmonary Hypertension	Not applicable	Recruiting	2021-06	Canada
Molecular Characteristics of Gastroesophageal Adenocarcinoma (MOCHA): A Prospective Feasibility Study NCT04219137 · ClinicalTrials.gov ↗ · Esophagogastric Adenocarcinoma	Observational	Recruiting	2019-11	Canada
Lattice Radiation Therapy Versus Conventional Radiation Therapy for the Palliation of Large Tumors NCT07444775 · ClinicalTrials.gov ↗ · Histopathologically or Cytologically Confirmed Solid Tumor Who Require Palliation Radiation Therapy to a Lesion ≥5cm	Phase 3	Recruiting	2025-11	Canada
Emotion and Symptom-Focused Engagement (EASE) for Caregivers NCT06367556 · ClinicalTrials.gov ↗ · Trauma and Stressor Related Disorders, Pediatric Cancer, Caregiver Burden	Not applicable	Recruiting	2025-02	Canada
Study of Venetoclax and Azacitidine in Advanced BCR-ABL Negative Myeloproliferative Neoplasms NCT05074355 · ClinicalTrials.gov ↗ · Myeloproliferative Neoplasm Drugs: Azacitidine, Venetoclax	Phase 2	Recruiting	2023-11	Canada
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) NCT05403177 · ClinicalTrials.gov ↗ · Breast Cancer, Colorectal Cancer, Pancreas Cancer	Observational	Recruiting	2022-06	Canada
Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition NCT06452095 · ClinicalTrials.gov ↗ · Long COVID, Post Acute Sequelae of COVID-19, Post-COVID-19 Condition	Not applicable	Recruiting	2026-01	Canada
Co-Adaptation of an Digital Pain Management Program for Canadian Veterans NCT07818980 · ClinicalTrials.gov ↗ · Chronic Pain, Veterans	Observational	Recruiting	2026-09	Canada
R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma NCT05345158 · ClinicalTrials.gov ↗ · Lymphadenopathy Retroperitoneal, Stage II Testicular Seminoma	Not applicable	Recruiting	2022-02	Canada
Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer NCT05656794 · ClinicalTrials.gov ↗ · Prostate Metastases	Phase 2	Recruiting	2023-08	Canada
Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients NCT07235683 · ClinicalTrials.gov ↗ · CMV, Lung Transplant Recipient Drug: Letermovir	Phase 4	Recruiting	2025-12	Canada
Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC NCT07698106 · ClinicalTrials.gov ↗ · Triple-Negative Breast Cancer (TNBC) Drug: Isunakinra	Phase 1/2	Recruiting	2026-10	Canada
Study to Investigate an Association Between Brain Activity and Tidal Volume in Humans (BATMAN) NCT06142773 · ClinicalTrials.gov ↗ · Ventilation Therapy; Complications	Not applicable	Recruiting	2023-11	Canada
Molecular Residual Disease Interception in Locoregionally-Advanced High Risk HPV+ and HPV- HNSCC NCT05414032 · ClinicalTrials.gov ↗ · Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Drug: Rilvegostomig	Phase 2	Recruiting	2023-07	Canada
Deep Brain Stimulation of the Pedunculopontine Nucleus for Alzheimer's Disease NCT06936124 · ClinicalTrials.gov ↗ · Alzheimer Disease	Not applicable	Recruiting	2025-05	Canada
Outcomes Post Treatment: Impact on Motor Impairment of Sleep Efficiency in SCI (OPTIMISE SCI Trial) NCT05473689 · Spinal Cord Injuries, Spine Disease	Not applicable	Recruiting	2022-08	Canada
Diagnosis of Graft Pathology by TruGraf NCT06557564 · ClinicalTrials.gov ↗ · Acute Graft Rejection	Observational	Recruiting	2024-07	Canada
Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery NCT06287619 · ClinicalTrials.gov ↗ · Chronic Iron Deficiency Anaemia, Cardiac Surgery	Phase 2	Recruiting	2025-04	Canada
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients NCT05938712 · ClinicalTrials.gov ↗ · Kidney Transplant Recipients Drugs: Dapagliflozin, Farxiga, Semaglutide	Phase 2	Recruiting	2023-10	Canada
Toronto Western Hospital (TWH) Waste Audit NCT06680284 · ClinicalTrials.gov ↗ · Audit of Medical Waste Disposal	Observational	Recruiting	2023-07	Canada
HN-QUEST: A Study of Head and Neck Imaging Biomarkers NCT05919290 · ClinicalTrials.gov ↗ · Head and Neck Squamous Cell Carcinoma	Not applicable	Recruiting	2023-07	Canada
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) NCT05592938 · Breast Cancer, Breast Cancer Recurrent	Not applicable	Recruiting	2023-06	Italy, Canada, Brazil, Australia, Israel
Heart Rate VAriability as a MaRker for tItrATing hIgh flOw Nasal Cannula Therapy NCT07518862 · ClinicalTrials.gov ↗ · Respiratory Failure, Heart Rate Variability (HRV), High Flow Nasal Cannula	Observational	Recruiting	2026-05	Canada
COgnitive-somatoSensory-MOtor Training to Improve Arm and Hand Function After Stroke (iCOSMO) NCT06498011 · ClinicalTrials.gov ↗ · Stroke, CVA, Cerebrovascular Accident	Not applicable	Recruiting	2024-08	Canada
Autologous BMA vs Saline and LAM + LP-PRP vs Saline Evaluations in Knee OA NCT05517434 · ClinicalTrials.gov ↗ · Osteoarthritis, Knee	Phase 2/3	Recruiting	2025-01	Canada
Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling NCT06529744 · ClinicalTrials.gov ↗ · Dementia, Alzheimer Disease, Dementia With Lewy Bodies	Observational	Recruiting	2023-11	Canada
Myeloproliferative Neoplasms (MPNs) Patient Registry NCT02760238 · ClinicalTrials.gov ↗ · Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia	Observational	Recruiting	2015-04	Canada
Study to Assess the Safety and Effects of Porphysome Nanoparticles for Imaging in Gynaecological Cancers NCT06977126 · ClinicalTrials.gov ↗ · Gynecological Cancers	Phase 1	Recruiting	2025-11	Canada
Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Cancer Patients NCT07535905 · ClinicalTrials.gov ↗ · Hypogonadism, Prostate Cancer Drug: Tamoxifen	Phase 2	Recruiting	2026-12	Canada
Durvalumab and Oleclumab in Resectable PDAC NCT06060405 · ClinicalTrials.gov ↗ · Pancreatic Ductal Adenocarcinoma Drugs: Durvalumab, Oleclumab	Phase 2	Recruiting	2023-11	Canada
Trial of a Virtual Exercise-based Rehabilitation Program to Treat Persistent Chemotherapy-Induced Peripheral Neuropathy (CIPN) NCT07481149 · ClinicalTrials.gov ↗ · Chemotherapy-induced Peripheral Neuropathy (CIPN)	Phase 3	Recruiting	2026-03	Canada
A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer NCT06451445 · ClinicalTrials.gov ↗ · Prostate Cancer	Not applicable	Recruiting	2024-05	Canada
Cervicothoracic Sympathetic Block Evaluation for Post COVID Condition NCT07468604 · ClinicalTrials.gov ↗ · Autonomic Dysfunction	Phase 4	Recruiting	2026-05	Canada
Umbrella Study for Single Patient Treatments in Oncology NCT06285500 · ClinicalTrials.gov ↗ · Advanced Cancer, Rare Diseases	Observational	Recruiting	2024-02	Canada
Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol) NCT06668454 · ClinicalTrials.gov ↗ · Esophageal Cancer, Gastric Cancer, Oligometastatic Disease	Not applicable	Recruiting	2025-05	Canada
Greater Occipital Nerve Block for Spontaneous Intracranial Hypotension NCT06374524 · ClinicalTrials.gov ↗ · Spontaneous Intracranial Hypotension	Observational	Recruiting	2024-08	Canada
A Study of Standard Of Care Versus Radio Ablation in Early Stage HCC NCT07628751 · ClinicalTrials.gov ↗ · Early Hepatocellular Carcinoma	Not applicable	Recruiting	2026-05	Canada, Australia
Using ctDNA to Determine Therapies for Lung Cancer NCT04966663 · ClinicalTrials.gov ↗ · Non Small Cell Lung Cancer, Complete Surgical Resection, Circulating Tumor DNA Drugs: Carboplatin, Cisplatin, Gemcitabine	Phase 2	Recruiting	2022-03	Canada
Plan Development for Giving Teclistamab in the Outpatient Setting NCT06251076 · ClinicalTrials.gov ↗ · Multiple Myeloma, Relapsed Cancer, Refractory Cancer Drugs: Teclistamab, Tocilizumab	Phase 4	Recruiting	2024-11	Canada
StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias NCT04843683 · ClinicalTrials.gov ↗ · Cardiac Arrhythmia	Not applicable	Recruiting	2021-12	Canada
Ontario-wide Cancer TArgeted Nucleic Acid Evaluation NCT02906943 · ClinicalTrials.gov ↗ · Breast Cancer, Lung Cancer, Colorectal Cancer	Observational	Recruiting	2016-08	Canada
Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer NCT05313815 · ClinicalTrials.gov ↗ · Prostate Cancer	Not applicable	Recruiting	2022-07	Canada
In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma NCT02811523 · ClinicalTrials.gov ↗ · Bone Sarcoma, Soft Tissue Sarcoma, Pulmonary Metastases Drug: Doxorubicin	Phase 1	Recruiting	2016-02	Canada
PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM) NCT06871176 · ClinicalTrials.gov ↗ · Multiple Myeloma Drug: [68Ga]Ga-PentixaFor	Not applicable	Recruiting	2025-04	Canada
Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL) NCT04574960 · ClinicalTrials.gov ↗ · Bladder Cancer, Bladder Urothelial Carcinoma Drugs: Carboplatin, Cisplatin, Gemcitabine	Phase 3	Recruiting	2021-02	Canada
Immune Resistance Interrogation Study NCT04243720 · ClinicalTrials.gov ↗ · Cancer, Solid Tumor, Metastatic Cancer	Observational	Recruiting	2020-08	Canada
Cannabinoids for Osteoarthritis Pain Effectiveness Trial NCT06878417 · ClinicalTrials.gov ↗ · Osteoarthritis of Knee, Osteoarthritis Hip Drug: Cannabis	Not applicable	Recruiting	2026-01	Canada
Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection NCT05254782 · ClinicalTrials.gov ↗ · Non Small Cell Lung Cancer	Observational	Recruiting	2021-07	Canada
CfDNA in Hereditary And High-risk Malignancies 2 NCT06726642 · ClinicalTrials.gov ↗ · Hereditary Cancer Syndrome	Observational	Recruiting	2024-04	Canada
FAZA PET/MRI in CLI Patients Pre and Post Revascularization NCT04054609 · ClinicalTrials.gov ↗ · Critical Limb Ischemia	Not applicable	Recruiting	2019-08	Canada
In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung NCT05611034 · ClinicalTrials.gov ↗ · Lung Metastases, Colorectal Cancer Metastatic, Colorectal Cancer Drug: Oxaliplatin	Phase 1	Recruiting	2023-02	Canada
Elective Adaptive Radiation With SBRT for Improved DurabilitY of Response NCT06831032 · ClinicalTrials.gov ↗ · Prostate Adenocarcinoma, Iliac Nodal Disease, Para-aortic Lymph Node Metastasis	Not applicable	Recruiting	2026-04	Canada
CHARM-COPD Program of Care NCT06253013 · ClinicalTrials.gov ↗ · Chronic Obstructive Pulmonary Disease	Not applicable	Recruiting	2023-09	Canada
meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis NCT05715814 · Peritoneal Dialysis Complication, End Stage Kidney Disease, Sodium-glucose Co-transporter-2 Inhibitors Drug: Dapagliflozin	Phase 3	Recruiting	2024-09	Canada
Partial Neuromuscular Blockade in Acute Hypoxemic Respiratory Failure NCT04524585 · ClinicalTrials.gov ↗ · Respiratory Insufficiency, Neuromuscular Blockade, Mechanical Ventilation Drug: Cisatracurium	Not applicable	Recruiting	2020-10	Canada
Diaphragm Structure and Pathobiology in Patients Being Bridged to Lung Transplant NCT03667027 · ClinicalTrials.gov ↗ · Diaphragm Injury, Respiratory Failure, Mechanical Ventilation Complication	Observational	Recruiting	2019-04	Canada
Effects of Compression Stockings in Asthma Symptoms at Night NCT03303586 · ClinicalTrials.gov ↗ · Asthma	Not applicable	Recruiting	2017-02	Canada
Circulating Tumor DNA in Soft Tissue Sarcoma NCT03818412 · ClinicalTrials.gov ↗ · Soft Tissue Sarcoma	Not applicable	Recruiting	2019-01	Canada
Registry for Patients Receiving Intravenous Nutrition at Home NCT02299466 · ClinicalTrials.gov ↗ · Parenteral Nutrition, Home	Observational	Recruiting	2005-12	Canada
Radiofrequency Ablation for Curative Treatment of Small Low-Risk Papillary Thyroid Cancer: Pilot Study NCT07376837 · ClinicalTrials.gov ↗ · Thyroid Papillary Carcinoma	Not applicable	Recruiting	2026-02	Canada
Diagnosing Frontotemporal Lobar Degeneration NCT02964637 · ClinicalTrials.gov ↗ · Corticobasal Syndrome, Progressive Supranuclear Palsy, Behavioral Variant Frontotemporal Dementia	Observational	Recruiting	2015-08	Canada
Improving Patient Sleep Prior to Elective Surgery NCT06762639 · ClinicalTrials.gov ↗ · Surgery	Not applicable	Recruiting	2025-01	Canada
Feasibility of Reducing Respiratory Drive Using the Through-flow System NCT05642832 · ClinicalTrials.gov ↗ · Respiratory Insufficiency, Diaphragm Injury, Lung Injury	Not applicable	Recruiting	2024-01	Canada
Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer NCT06335914 · ClinicalTrials.gov ↗ · Advanced Prostate Cancer	Not applicable	Recruiting	2025-04	Canada
A Study of Head and Neck MRI and Tumor Microenvironment Biomarkers NCT06085781 · ClinicalTrials.gov ↗ · Squamous Cell Carcinoma of Head and Neck	Not applicable	Recruiting	2024-01	Canada
3T MRI in Patients With Deep Brain Stimulation (DBS) NCT03153670 · ClinicalTrials.gov ↗ · Neuro-Degenerative Disease	Not applicable	Recruiting	2017-06	Canada
Topical TRanexamic Acid vs. Placebo on Acute Postoperative Pain Following DRF Fixation NCT06384456 · ClinicalTrials.gov ↗ · Distal Radius Fractures Drug: Tranexamic Acid	Phase 4	Recruiting	2025-08	Canada
Perioperative Vitamin C to Reduce Persistent Pain After Total Knee Arthroplasty NCT06123715 · ClinicalTrials.gov ↗ · Chronic Pain, Knee Pain Chronic, Post Operative Pain Drug: Vitamin C	Phase 2	Recruiting	2024-04	Canada
MR Guidance for Liver and Pancreas NCT03582189 · ClinicalTrials.gov ↗ · Magnetic Resonance Imaging	Observational	Recruiting	2018-07	Canada
Study of the Safety and Usefulness of Liposomal Curcumin in Multiple Myeloma NCT07456605 · ClinicalTrials.gov ↗ · Multiple Myeloma Refractory, Multiple Myeloma in Relapse	Phase 1	Recruiting	2026-02	Canada
Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma NCT04510636 · ClinicalTrials.gov ↗ · Classical Hodgkin Lymphoma, Relapsed Cancer, Refractory Cancer Drugs: Bendamustine, Keytruda, Pembrolizumab	Phase 2	Recruiting	2021-12	Canada
Effect of Hi-OxSR for the Treatment of Post COVID Condition NCT06928506 · ClinicalTrials.gov ↗ · Long COVID, Post COVID-19 Condition, Post Acute Sequelae of COVID-19	Not applicable	Recruiting	2025-08	Canada
Cabozantinib to Treat Recurrent Liver Cancer Post Transplant NCT04204850 · ClinicalTrials.gov ↗ · Hepatocellular Carcinoma, Recurrent Cancer, Liver Transplant Drug: Cabozantinib	Phase 2	Recruiting	2020-08	Canada
Feasibility of Early Swallowing and Speech Intervention for Head and Neck Cancer Patients Treated SURGically NCT06192771 · ClinicalTrials.gov ↗ · Dysphagia, Head and Neck Cancer	Not applicable	Recruiting	2023-12	Canada
A Trial of ABSK043, an Oral PD-L1 Inhibitor, in Patients With Angiogenic Sarcomas NCT07014137 · ClinicalTrials.gov ↗ · Sarcoma Drug: ABSK043	Phase 2	Recruiting	2025-09	Canada

Showing the 100 most recently updated of 356 trials (recruiting first). The rest are in the country registers linked in each row.

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in University Health Network, Toronto trials

128 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

+ 88 more in the trial list above.

Conditions in University Health Network, Toronto trials

497 conditions

Breast Cancer16 Cancer15 Prostate Cancer12 Advanced Cancer10 Lung Cancer9 Colorectal Cancer9 Chronic Pain6 Solid Tumor5 Hepatocellular Carcinoma4 Melanoma4 Metastatic Cancer4 Sarcoma4 Surgery4 Spinal Cord Injuries4 Stroke4 Non-small Cell Lung Cancer4Respiratory Insufficiency3Ovarian Cancer3 Fallopian Tube Cancer3 Gynecologic Cancer3OligoProgressive Metastatic Disease3Testicular Cancer3Prostate Cancer (Adenocarcinoma)3 Soft Tissue Sarcoma3

By trial register

Register	Trials	Recruiting
Clinical trials in Canada	356	204
Clinical trials in Australia	6	5
Clinical trials in Spain	5	3
Clinical trials in Italy	3	3
Clinical trials in Singapore	2	2
Clinical trials in Ireland	1	1
Clinical trials in France	1	0
Clinical trials in Belgium	1	0
Clinical trials in Switzerland	1	0
Clinical trials in Austria	1	0
Clinical trials in Brazil	1	1
Clinical trials in Israel	1	1

A trial with sites in more than one country appears in each of those registers; recruiting counts cover the trials listed on this page.

Other sponsors in Breast Cancer

Sponsor	Trials
Fudan University	50
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	21
AstraZeneca	18
Second Affiliated Hospital, Zhejiang University, School of Medicine	18
Institut du Cancer de Montpellier - Val d'Aurelle	16
Sunnybrook Health Sciences Centre	15
Shengjing Hospital	15
European Institute of Oncology	14
Pfizer	12
The Netherlands Cancer Institute	12

Sponsors with the most current trials registered for this condition.

Questions about University Health Network, Toronto trials

How many clinical trials does University Health Network, Toronto sponsor?

University Health Network, Toronto is the lead sponsor of 356 current trials on ClinicalTrials.gov in our Canada, Australia, Spain, Italy, Singapore, Ireland, France, Belgium, Switzerland, Austria, Brazil and Israel registers, as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.

Are University Health Network, Toronto trials recruiting?

Yes. 204 of its 356 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is University Health Network, Toronto testing?

Its current trials name 128 drugs and biologicals as interventions. The most frequent are Cisplatin (5), Cyclophosphamide (5), Carboplatin (4), Durvalumab (4) and Gemcitabine (4). The number in brackets is how many of its trials name each drug.

Does University Health Network, Toronto have clinical trials in Ireland?

Yes. 1 trial in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.